Aula sobre Trasplantes de Órganos Sólidos - Roche Trasplantes

Tratamiento y Prevención - Ponencias25. Meiser BM, Billingham ME, Morris RE. Effects of cyclosporin,FK506, and rapamycin on graft-vessel disease. Lancet1991; 338(8778): 1297-8.26. Gregory CR, Huang X, Pratt RE, Dzau VJ, Shorthouse R, BillinghamME, Morris RE. Treatment with rapamycin andmycophenolic acid reduces arterial intimal thickening producedby mechanical injury and allows endothelial replacement.Transplantation 1995; 59(5): 655-61.27. Nagamine S, Ohmi M, Tabayashi K, Iguchi A, Mohri H. Effectsof cyclosporine and 15-deoxyspergualin on coronary arteriosclerosisafter heart transplantation in the rat. J HeartLung Transplant; 13(5): 895-8.28. Kahan BD. Efficacy of sirolimus compared with azathioprinefor reduction of acute renal allograft rejection: a randomisedmulticentre study. The Rapamune US Study Group. Lancet2000; 356(9225): 194-202.29. Halle AA 3rd, DiSciascio G, Massin EK, Wilson RF, Johnson MR,Sullivan HJ, Bourge RC, Kleiman NS, Miller LW, Aversano TR, etal. Coronary angioplasty, atherectomy and bypass surgery in cardiactransplant recipients. J Am Coll Cardiol 1995; 26(1): 120-8.30. Heublein B, Pethig K, Maass C, Wahlers T, Haverich A. Coronaryartery stenting in cardiac allograft vascular disease.Am Heart J 1997; 134(5 Pt 1): 930-8.31. Wong PM, Piamsomboon C, Mathur A, Chastain HD 2nd,Singh DJ, Liu MW, Parks JM, Iyer S, Dean LS, Baxley WA,Bourge RC, Roubin GS. Efficacy of coronary stenting in themanagement of cardiac allograft vasculopathy. Am J Cardiol1998; 82(2): 239-41.32. Chan AW, Carere RG, Khatri S, Della Siega A, IgnaszewskiAP, Webb JG. Unprotected left main coronary artery stentingfor cardiac allograft vasculopathy. J Heart Lung Transplant2001; 20(7): 776-80.33. Klauss V, Stempfle H, Theisen K, Kantlehner R, Poellinger B,Reichart B, Schiele TM. Vascular brachytherapy for treatmentof cardiac allograft vasculopathy. J Heart Lung Transplant2001; 20(7): 792-4.34. Mehra MR, Uber PA, Prasad AK, Park MH, Scott RL, McFaddenPM, Van Meter CH. Long-term outcome of cardiac allograftvasculopathy treated by transmyocardial laser revascularization:early rewards, late losses. J Heart Lung Transplant2000; 19(8): 801-4.35. Karwande SV, Ensley RD, Renlund DG, Gay WA Jr, RichenbacherWE, Doty DB, Hammond ME, Marks JD. Cardiac retransplantation:a viable option? The Registry of the InternationalSociety for Heart and Lung Transplantation. AnnThorac Surg 1992 Nov; 54(5): 840-4.36. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ.The Registry of the International Society for Heart and LungTransplantation: eighteenth Official Report-2001. J HeartLung Transplant 2001; 20(8): 805-15.157